genprowebdirectory
GEN Edge
Latest News
Login
Subscribe
News
Insights
Trends for 2020
Trends for 2021
Topics
Bioprocessing
Cancer
Drug Discovery
Genome Editing
OMICs
Translational Medicine
A-Lists
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Resources
All
GEN Live
Webinars/Virtual Events
eBooks
Podcasts
Tutorials
Peer-Reviewed Journals
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Create an account
Privacy Policy
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Latest News
Login
Subscribe
News
Biomarkers
Engineering Exosomes for Clinical Applications
Cancer
Cancer Formation Linked to Phase Separation
Eye Disorders
Macular Degeneration Linked to Inability to Remove Damaged Photoreceptors
Neurological Disorders
Study Finetunes Bioelectronic Medicine, Specifying Efficacy of Vagal Nerve Stimulation Therapy
Antibodies
Antibody Therapy Rescues Mice from Lethal Form of Congenital Myasthenia
Insights
All
Trends for 2020
Trends for 2021
Biomarkers
Engineering Exosomes for Clinical Applications
Antibodies
Tech Advances Will Help mAb Sector Adopt Continuous Production
Antibodies
Optimizing a Continuous Bioprocess with a Digital Twin
Bioprocessing
Yposkesi’s New Facility to Support Viral Vector Demand
Topics
Bioprocessing
Cancer
Drug Discovery
Genome Editing
OMICs
Translational Medicine
A-Lists
A-Lists
Top 8 Best-Selling COVID-19 Vaccines and Drugs of Q1 2021
A-Lists
Top 10 Life Sciences Jobs Most in Demand over the Next…
A-Lists
Top 10 U.S. Biopharma Clusters
A-Lists
Top 7 Best Selling COVID-19 Vaccines and Drugs of 2020
A-Lists
Seven Biopharma Trends to Watch in 2021
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Resources
All
GEN Live
Webinars/Virtual Events
eBooks
Podcasts
Tutorials
Peer-Reviewed Journals
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Authors
Posts by Susan Aldridge, PhD
Susan Aldridge, PhD
85 POSTS
0 COMMENTS
Susan Aldridge, PhD, is a writer for GEN.
December 1 2010 Vol. 30 No. 21
Filtration Improvements Yield Many Benefits Down the Line
August 1 2010 Vol. 30 No. 14
Strategies for Successful Process Scale-Up
Insights
Pharma’s R&D Focus Shifting to Stem Cells
Insights
Promise of Regenerative Medicine Closer to Reality
Insights
Hungary Bids for Prime Spot in EU Biotech
Insights
New Predictive ADME/Tox Strategies Reduce Attrition
February 1 2010 Vol. 30 No. 3
Epigenetics Offers Strategies for New Drugs
Insights
Advancing Stem Cell Therapies for Multiple Sclerosis
Insights
Coping Strategies for Cash-Strapped Firms
Columns
Will the U.K. Lead on Regenerative Medicine?
1
2
3
...
9
Page 1 of 9
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
